<DOC>
<DOCNO>
EP-0002202
</DOCNO>
<TEXT>
<DATE>
19790613
</DATE>
<IPC-CLASSIFICATIONS>
C12N-5/00 C07F-9/00 C07F-9/09 A01N-57/12 <main>C07F-9/09</main> C07F-9/10 A01N-57/00 A01H-3/04 C12N-5/10 A01H-1/02 C07F-9/6539 A01H-3/00 B01F-17/14 
</IPC-CLASSIFICATIONS>
<TITLE>
phospholipid compounds, process for their preparation and their use.
</TITLE>
<APPLICANT>
max planck gesellschaftde<sep>max-planck-gesellschaft zur forderung der wissenschaften e.v.<sep>max-planck-gesellschaft zur förderung der wissenschaften e.v.bunsenstrasse 10d-37073 göttingende<sep>max-planck-gesellschaft zur forderung der wissenschaften e.v.<sep>
</APPLICANT>
<INVENTOR>
eibl hansjorg dr<sep>eibl, hansjorg, dr.<sep>eibl, hansjörg, dr.steinweg 51d-3406 bovendende<sep>eibl, hansjorg, dr.<sep>eibl, hansjörg, dr.steinweg 51d-3406 bovendende<sep>
</INVENTOR>
<ABSTRACT>
New phospholipidal compounds of general formula I wherein alk is a straight-chain, branched or cyclic alkyl group having 2 to 12 C atoms, a group -NH₂ or R₁ the remainder of a mono- or polyhydric aliphatic primary or secondary alcohol whose optional other OHor esterified groups and contain ostieres and contain the ester or ether groups 1 to 26 C atoms and optionally one or more carbon multiple bonds, wherein R₁ contains overall at least 6 C atoms, R₂, R₄ and R₆ is hydrogen or an alkyl group with 1 to 4C atoms, R₃ and R₅ is hydrogen or an alkyl group having 1 to 4 C atoms or a free electron pair, X and Y independently of each other, respectively, the number 1, 2, 3, 4 or 5 are suitable for changing cell membranes for effectof cell fusions, as emulsifiers and medicines.
</ABSTRACT>
</TEXT>
</DOC>
